# Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer

> **NCT00425152** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 2151 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** levamisole hydrochloride

## Key facts

- **NCT ID:** NCT00425152
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-07
- **Primary completion:** 1998-06
- **Final completion:** 2004-04
- **Target enrollment:** 2151 (ACTUAL)
- **Last updated:** 2010-02-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425152, "Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00425152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*